The MedTech Edge: June 2026 Edition

Strategies, regulatory intel, and expert guidance across the full lifecycle of MedTech innovation: concept to commercialization. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

View in browser

This month, we’re exploring what it takes to navigate complexity in today’s medtech landscape, from the critical role of ethnographic research in shaping better solutions to the evolving regulatory and operational demands facing teams across the product lifecycle. Inside, you’ll find insights on strengthening your preclinical approach, closing compliance gaps, and making smarter decisions, along with the latest updates and opportunities to connect with experts in the field.

This Month's Service Spotlights

Design Instructions Users Actually Follow
Great devices fail when instructions are unclear in real workflows. We craft packaging artwork, iconography, and instructional content, including IFUs and QRGs, to strengthen comprehension and usability for submission and launch.

Learn More

Learning Opportunities

MEET OUR EXPERTS IN PERSON

View All Events

Industry Insights From Our Experts

What MedTech Investors Will Demand in 2026 and Beyond

If you can't walk someone through your integrated evidence plan in 90 seconds, the meeting ends there.

Europe Is Rewriting the Rules on Medical Devices

For startups, mid-size manufacturers or "strategics" these changes will reshape your compliance roadmap.

Missing Cybersecurity Artifacts Can Kill Your Submission

What software & engineering teams need to plan, document, and prove before you get to the finish line. Start by keeping a "Zero Trust" mindset.

Market Access: Evaluating Your Right to Play in Women's Health

Why the blind spot between personal experience and population reality is where well-intentioned solutions go to die.

FDA Opened a New Door on Real-World Evidence. Don't Walk Through It Unprepared

Three regulatory pathways are now more accessible. IF your evidence strategy is designed to take advantage of them.

Six Signs You're Not Ready for GLP: The Histology Perspective

Histopathology requirements frequently get treated as presumptive afterthoughts, until tissue processing reveals that your study wasn't ready to begin.

Product Design & Engineering
Preclinical & Pathology | Clinical Research (CRO)

Regulatory Quality | Commercialization